Tuberculosis-related stigma among adults presenting for HIV testing in KwaZulu-Natal, South Africa.
HIV
South Africa
Stigma
Tuberculosis
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
03 Sep 2020
03 Sep 2020
Historique:
received:
13
08
2019
accepted:
12
08
2020
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
15
5
2021
Statut:
epublish
Résumé
Tuberculosis (TB)-related stigma presents a major barrier to care of persons with TB through its impact on treatment initiation and retention in care. This is particularly challenging in settings with high prevalence of both TB and HIV where fear of HIV/AIDS can amplify stigma surrounding TB. The purpose of this study was to validate a TB stigma scale for use among persons presenting for outpatient HIV screening in the Umlazi township of South Africa and evaluate factors associated with TB-related stigma in this high HIV burden setting. In this cross-sectional study, we measured TB-related stigma in adults prior to HIV testing using a 12-item scale designed to assess experienced and felt TB-related stigma. Among 848 adults, mean age was 32 years, 54% were male, and the median TB stigma score was 19 of 36 (interquartile range 15-23). We identified two factors in the stigma scale which had excellent reliability (Cronbach's alpha 0.85, 0.89). Persons with high TB stigma were more likely to be male (adjusted relative risk ratio [aRRR] 1.56, 95% confidence interval [CI] 1.11-2.28) and have accurate knowledge of TB transmission (aRRR 1.90, 95% CI 1.16-3.10) as compared to those with low stigma. Variables not significantly associated with stigma in the multivariate model included education, income, prior TB or HIV diagnoses, and depression. Male sex and TB knowledge were associated with higher TB stigma in an outpatient HIV clinic in a South African township. Identifying risk factors associated with stigma will be important to guide stigma reduction interventions.
Sections du résumé
BACKGROUND
BACKGROUND
Tuberculosis (TB)-related stigma presents a major barrier to care of persons with TB through its impact on treatment initiation and retention in care. This is particularly challenging in settings with high prevalence of both TB and HIV where fear of HIV/AIDS can amplify stigma surrounding TB. The purpose of this study was to validate a TB stigma scale for use among persons presenting for outpatient HIV screening in the Umlazi township of South Africa and evaluate factors associated with TB-related stigma in this high HIV burden setting.
METHODS
METHODS
In this cross-sectional study, we measured TB-related stigma in adults prior to HIV testing using a 12-item scale designed to assess experienced and felt TB-related stigma.
RESULTS
RESULTS
Among 848 adults, mean age was 32 years, 54% were male, and the median TB stigma score was 19 of 36 (interquartile range 15-23). We identified two factors in the stigma scale which had excellent reliability (Cronbach's alpha 0.85, 0.89). Persons with high TB stigma were more likely to be male (adjusted relative risk ratio [aRRR] 1.56, 95% confidence interval [CI] 1.11-2.28) and have accurate knowledge of TB transmission (aRRR 1.90, 95% CI 1.16-3.10) as compared to those with low stigma. Variables not significantly associated with stigma in the multivariate model included education, income, prior TB or HIV diagnoses, and depression.
CONCLUSIONS
CONCLUSIONS
Male sex and TB knowledge were associated with higher TB stigma in an outpatient HIV clinic in a South African township. Identifying risk factors associated with stigma will be important to guide stigma reduction interventions.
Identifiants
pubmed: 32883251
doi: 10.1186/s12889-020-09383-0
pii: 10.1186/s12889-020-09383-0
pmc: PMC7469347
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1338Subventions
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : Harvard University Center for AIDS Research
ID : AI060354
Organisme : National Institute of Allergy and Infectious Diseases
ID : AI108293
Références
BMC Public Health. 2010 Feb 17;10:72
pubmed: 20163702
Tuberc Res Treat. 2019 May 2;2019:5917537
pubmed: 31186957
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):81-86
pubmed: 29025489
Clin Infect Dis. 2016 May 15;62 Suppl 3:S244-54
pubmed: 27118854
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):42-48
pubmed: 29025484
Am J Trop Med Hyg. 2015 Mar;92(3):625-32
pubmed: 25510722
BMC Public Health. 2011 Aug 30;11:675
pubmed: 21878102
Trop Med Int Health. 2008 Jan;13(1):21-30
pubmed: 18290998
Soc Sci Med. 2012 May;74(10):1512-9
pubmed: 22444460
Trop Med Int Health. 2018 Feb;23(2):199-205
pubmed: 29178244
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Int J Tuberc Lung Dis. 2011 Nov;15(11):1540-5, i
pubmed: 22008770
Int J Tuberc Lung Dis. 2006 Sep;10(9):1008-12
pubmed: 16964792
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Int J Tuberc Lung Dis. 2014 Feb;18(2):168-73, i-iv
pubmed: 24429308
Int J Tuberc Lung Dis. 2006 Sep;10(9):1013-7
pubmed: 16964793
Public Health Action. 2014 Dec 21;4(4):226-232
pubmed: 25580382
Int J Equity Health. 2011 Jan 14;10:2
pubmed: 21235762
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):60-68
pubmed: 29025486
BMJ. 1997 Feb 22;314(7080):572
pubmed: 9055718
BMC Infect Dis. 2017 Jul 21;17(1):510
pubmed: 28732485
BMC Res Notes. 2010 Oct 04;3:249
pubmed: 20920360
AIDS Behav. 2009 Dec;13(6):1160-77
pubmed: 19636699
Res Nurs Health. 2001 Dec;24(6):518-29
pubmed: 11746080
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):87-96
pubmed: 29025490
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):75-80
pubmed: 29025488
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):19-25
pubmed: 29025481
BMC Health Serv Res. 2011 May 20;11:110
pubmed: 21599883